Ireland's Five-Year Research Strategy to Boost PhD Graduates and Innovation Spin-Outs

Ireland’s Five-Year Research Strategy to Boost PhD Graduates and Innovation Spin-Outs


**Ireland’s Ambitious Five-Year Strategy to Enhance Research and Innovation**

Ireland has recently introduced an extensive five-year plan designed to strengthen its research and innovation framework, as it endeavors to reinforce its economy and society through knowledge-based advancement. The newly formed Research Ireland, created from the merger of Science Foundation Ireland and the Irish Research Council, will lead this change, aspiring to be more than just a funding organization by actively influencing the research atmosphere.

**Three Pillar Strategy: Talent, Economy, and Society**

The strategy is built on three core pillars: talent enhancement, economic development, and societal advantage. By targeting the production of 3,800 PhDs and 2,000 postdoctoral fellows within five years, in addition to backing 14 national research centers, Ireland aims to inject new talent into its research sector across economically vital fields.

**Beyond Funding: Driving Economic Benefits**

A recurring theme throughout the strategy is the aspiration for Research Ireland to rise above conventional funding roles and provide tangible economic advantages. This encompasses nurturing international partnerships and fostering commercialization via university spin-outs, with a bold aim to launch 50 new enterprises. Prior investments highlight the momentum, with a historic €4.55 billion allocated over five years to enhance the research ecosystem, following a €2.9 billion earmarked for 2021 to 2025.

**Investing in Infrastructure and Talent**

James Lawless, the minister for higher education and research, underscores the vital need for significant investment in infrastructure and talent. By expanding research capabilities, the strategy seeks to bolster the growth of Irish businesses, embed global investments, and promote job creation. Nonetheless, Ireland’s reliance on foreign direct investment, particularly from US pharmaceutical and tech companies such as Pfizer and Johnson & Johnson, raises concerns. US firms alone are projected to significantly contribute to the Irish economy, employing around 245,000 individuals by 2024.

**Fostering Links with Venture Capital and Industry**

The strategy also emphasizes the necessity of establishing stronger connections with venture capital and entrepreneurial circles, advocating for enhanced collaboration with both domestic and international organizations to boost Ireland’s long-term competitiveness. Funds are designated, with a notable 25% of investigator-led grants assigned to life sciences, 13% to social sciences and humanities, and 25% to physical sciences and engineering.

**Addressing the Investment Gap**

Despite these efforts, the strategy recognizes ongoing challenges. It points out inconsistencies in governmental investment, an imbalance between public and private funding, and lower rates of intellectual property generation in comparison to similar economies such as Austria, Belgium, Denmark, Finland, and the Netherlands. The document stresses the need for Ireland to strategically align its research resources for optimal impact, utilizing strong global research trends, especially in Asia and the UK.

**Boosting SME Participation in Horizon Europe**

To further embed Irish research within the European framework, Minister Lawless also launched an action plan aimed at enhancing the involvement of Irish SMEs in the Horizon Europe initiative, valued at €95.5 billion. This plan seeks to assist institutions, first-time EU project applicants, and promote leading roles for Irish contributors.

In conclusion, Ireland’s new research and innovation strategy marks a significant move towards reshaping the nation’s research ecosystem, aiming not only to secure its economic future but also to cultivate a sustainable, innovation-led society.